Sorry, you need to enable JavaScript to visit this website.
Skip to main content

This site is intended for US Population-Health Decision Makers or similar entities at hospitals and US oncology practices.

Real-world PV QI Impact

Pontchartrain Cancer Center Case Study

Real-world Impact of Quality Initiatives on Patients With High-Risk PV

Polycythemia Vera (PV) Quality Initiative in Action

For an insider’s view of a real-world QI, watch Kathy Oubre, MS (CEO) from the Pontchartrain Cancer Center in Southeast Louisiana as she describes how the practice championed a Quality Initiative (QI) to improve patient care in PV. Hear about the importance of provider buyin and feedback on workflows. Garner first-hand advice about tracking and monitoring patients, and discover the benefits of basing the QI on a collaborative care approach.

The Plan

  • The staff at Pontchartrain Cancer Center in Southeast Louisiana identified a focus to help improve the care for patients with PV
  • Because of the rare nature of PV, the patients with PV that they identified for intervention meant implementing a QI would not be time-consuming
  • Small workflow refinements could provide value for their patients and allow the care team to work collaboratively1

The QI Components

  1. Electronic medical record review to quickly identify patients with PV
  2. Determine goals for lab values, frequency of labs, and when to medically intervene
  3. Follow-up lab testing for better management of patients with PV

The Results

Real-world results achieved through:

The center used their EMR system to identify patients with PV whose lab values and care plans they wanted to review, and ensured better provider collaboration and patient follow-up where warranted.

Collaboration
Patient Identification
Intervention

23 patients with PV were identified, 7 (30%) of whom had Hct levels >45%1

By integrating follow-up lab testing into the workflow, a specific, vulnerable subgroup of patients could be better managed1

Adjustments were made to care plans—in some cases, multiple times—for the 7 patients identified with Hct levels >45%1

For patients whose lab values were not within the target range, more frequent scheduling and reviewing of lab tests were recommended1

The additional monitoring required minimal time investment for nursing and allied HCPs already responsible for the direct care and management for patients with PV, creating a more proficient approach to PV management.1

HCP=healthcare provider; Hct=hematocrit; PV=polycythemia vera.

Download a PDF of a brochure

Polycythemia Vera (PV) Quality Initiative (QI) in Action

Do you want advice on ways to help improve quality and patient care in PV? See the steps the Pontchartrain Cancer Center took to implement their Quality Initiative for patients with PV, understand their effective monitoring strategy and the real-world impact it had, and get tips for success from the perspective of a CEO, a registered nurse, and a nurse practitioner.

Do you want advice on ways to help improve quality and patient care in PV? See the steps the Pontchartrain Cancer Center took to implement their Quality Initiative for patients with PV, understand their effective monitoring strategy and the real-world impact it had, and get tips for success from the perspective of a CEO, a registered nurse, and a nurse practitioner.

Reference: 1. Quality Initiatives in action: real world impact on patients with polycythemia vera. © 2021, Incyte Corporation.